IFNA1 and autoimmune disease: However, previous studies have also demonstrated increased B cell activity with IL-1052, potential therapeutic benefits of IL-10 inhibition in SLE53, 54; and pro-inflammatory effects of IL-10 in an IFN-dominated milieu55, suggesting a complex role for IL-10 in autoimmune diseases.